Mode
Text Size
Log in / Sign up

Higher fasting glucose-to-HDL ratio associated with increased MASLD risk in non-diabetic Japanese adultsHigh Blood Sugar Ratio Signals Liver Trouble Even Without Diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the glucose-to-HDL ratio as a potential observational biomarker for MASLD in non-diabetic Japanese adults.

In a cross-sectional analysis of 13,682 non-diabetic Japanese adults from the NAGALA cohort (2004–2015), researchers examined the association between the fasting blood glucose to high-density lipoprotein cholesterol ratio (GHR) and metabolic dysfunction-associated steatotic liver disease (MASLD) risk. The overall prevalence of MASLD was 15.25% (n = 2,087). The mean GHR was significantly higher in participants with MASLD (4.93 ± 1.14) compared to those without (3.59 ± 1.07).

The primary analysis showed a positive association between GHR and MASLD risk. For each 1-unit increase in GHR, the odds of having MASLD were 23% higher (odds ratio 1.23, 95% confidence interval 1.15 to 1.31). The study did not report specific safety or tolerability data related to the biomarker measurement.

Key limitations include the cross-sectional design, which cannot establish causality or temporal sequence. The study population was exclusively non-diabetic Japanese adults, limiting generalizability to other ethnic groups or individuals with diabetes. The comparator for the GHR metric was not reported, and the analysis did not adjust for all potential confounders. The findings suggest GHR may be a simple biomarker associated with MASLD presence in this specific population, but its clinical utility for risk prediction or monitoring requires prospective evaluation.

  • The Link: A specific ratio of blood sugar to good cholesterol predicts fatty liver disease.
  • The Group: This applies to healthy adults who do not have diabetes.
  • The Catch: It is a research finding, not a new medicine available today.

One simple number could warn you

A single number in your blood test might tell a hidden story about your liver.

Many people worry about diabetes or high cholesterol. But what about those in between?

Fatty liver disease is becoming very common. It affects millions of adults. Often, people feel fine until the liver gets damaged. Current tests miss many cases. Doctors need better warning signs.

The surprising shift

We used to think only diabetics had this risk. We also thought only overweight people were in danger. But this new data changes that view.

Here is the twist. Even if you are not diabetic, your liver might still be struggling. The key is how your blood sugar and good cholesterol work together.

What scientists didn't expect

Scientists found a non-linear relationship. This means the risk does not go up in a straight line. It jumps at certain points.

Think of a light switch. Turning it slightly might not change much. But flipping it fully turns the lights on. Your body works similarly. Small changes in your ratio matter less than big ones.

How the body handles this

Imagine your blood vessels are a busy highway. Glucose and cholesterol are cars driving on it.

When there are too many cars, traffic jams happen. These jams cause damage to the road. In your body, this damage happens to the liver cells.

But here is the catch. Body size plays a huge role. Being larger puts more cars on the road. This study shows that body size explains part of the risk. However, the ratio itself is a unique warning sign.

The study snapshot

Researchers looked at over 13,000 Japanese adults. These people did not have diabetes. They were part of a large health group called NAGALA.

The team checked their blood sugar and cholesterol levels. They also measured their liver health. They followed these people for years to see who developed the disease.

The study found that 15% of these adults had fatty liver disease. Those with the disease had a much higher ratio.

For every one-unit increase in the ratio, the risk of disease went up by 23%. This is a significant jump. It means the number is a strong predictor.

The risk does not stay flat. It gets worse as the number gets higher. This helps doctors spot patients who need attention sooner.

But there is a catch

This does not mean you can ignore your current test results.

The study shows a strong link. But it also shows that body size matters. If you are larger, the risk is naturally higher. The ratio helps separate the true risk from the weight risk.

Where this fits in the picture

Experts say this is a useful tool. It adds to the list of things doctors check. It helps explain why some normal-weight people get sick.

It also helps explain why some heavier people stay healthy. The ratio gives a clearer picture than weight alone.

You do not need to change your diet today based on this. But you should know what to ask your doctor.

Ask about your fasting blood sugar. Ask about your HDL cholesterol. This is the "good" cholesterol that protects your heart and liver.

If your ratio is high, talk to your doctor. They can check your liver health. Early detection is the best way to prevent damage.

The study has limits

This study looked at Japanese adults. Results might differ for other groups. The study was also a snapshot in time. It did not follow people for decades.

These limits are important. They mean we must be careful with the results. More research is needed to confirm these findings everywhere.

Scientists will likely study this ratio in other populations. They will also test if it works for different ages.

Eventually, this could become a standard part of check-ups. It might help doctors catch problems earlier. Until then, keep your blood tests up to date.

Your health is in your hands. Knowing your numbers is the first step.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThe fasting blood glucose (FBG) to high-density lipoprotein cholesterol (HDL-C) ratio (GHR) integrates glucose and lipid metabolism, but its association with metabolic dysfunction-associated steatotic liver disease (MASLD) is unclear. We aimed to investigate the relationship between GHR and MASLD and to quantify the mediating role of body mass index (BMI) in non-diabetic adults.MethodsThis cross-sectional study included 13,682 non-diabetic Japanese adults from the NAGALA cohort (2004–2015). Logistic regression was used to examine the association between GHR and MASLD risk, while generalized additive models (GAMs) and smooth curve fitting were used to investigate their non-linear relationship. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic efficacy of GHR for MASLD, and mediation analysis was conducted to assess the mediating effect of BMI in this association.ResultsThe prevalence of MASLD was 15.25% (n = 2,087). GHR was significantly higher in participants with MASLD (4.93 ± 1.14 vs. 3.59 ± 1.07). After multivariable adjustment, each 1-unit increase in GHR was associated with a 23% higher risk of MASLD (OR 1.23, 95% CI 1.15–1.31). A threshold effect was identified, with the risk escalating progressively when GHR 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.